Sp1 overexpression is a negative prognostic marker in pancreatic cancer and gastric cancer36, 37 and Sp1 downregulation inhibits cell survival of rhabdomyosarcoma38. This evidence concerns the gene SP1 and familial pancreatic carcinoma.